A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Tofacitinib Citrate Racemic Mixure | CAS 2664002-63-3 - Solicitar cotización

media.product.imagealternatetextformat.details

Tofacitinib Citrate Racemic Mixure

N° de SZ CAT:SZ-T010094
Número CAS
2664002-63-3
Mol.F.
C16H20N6O : C6H8O7
Peso Molecular
312.4 : 192.1
Status de Fatura
Synthesis on demand
Rel. CAS No344418-92-4 (free base)

Nome Químico :

Temperatura de envío :

Código HSN :

País de origen :

Sorrisos :

Nota de Uso:

Tofacitinib Citrate Racemic Mixure is chemically 3-(4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate. Tofacitinib Citrate Racemic Mixure is supplied with detailed characterization data compliant with regulatory guideline. Tofacitinib Citrate Racemic Mixure can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Tofacitinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Aplicaciones y casos de uso regulatorios

Comprar 2664002-63-3

Comprar 2664002-63-3

Encomendar 2664002-63-3

Consultar 2664002-63-3

price of 2664002-63-3

2664002-63-3 Fornecedor

2664002-63-3 Fabricante

2664002-63-3 Exportador

buy high quality Tofacitinib Citrate Racemic Mixure

Comprar Tofacitinib Citrate Racemic Mixure

Tofacitinib Citrate Racemic Mixure fornecedores

Tofacitinib Citrate Racemic Mixure fabricantes

Tofacitinib Citrate Racemic Mixure preço

Encomendar Tofacitinib Citrate Racemic Mixure

Consultar Tofacitinib Citrate Racemic Mixure

Tofacitinib Citrate Racemic Mixure custo

Tofacitinib Citrate Racemic Mixure Fornecedor

Tofacitinib Citrate Racemic Mixure Distribuidor

Tofacitinib Citrate Racemic Mixure Para validación de métodos

Tofacitinib Estándar de referencia

Tofacitinib Citrate Racemic Mixure Para presentación ANDA

Tofacitinib Citrate Racemic Mixure Para estudios de degradación forzada

Tofacitinib Citrate Racemic Mixure Estándares de identificación

Tofacitinib Citrate Racemic Mixure Para presentación DMF

ℹ️

Isenção de responsabilidade

As informações do produto SynZeal fornecidas neste site são baseadas no entendimento existente no momento da publicação. O cliente é responsável por avaliar a precisão das informações no momento da compra.

A SynZeal atualizará estes detalhes conforme novos desenvolvimentos ou descobertas nas especificações do produto, sem aviso prévio.

,